{"title": "488 Acetaminophen, 99-100, 100f, 446 Achlorhydria, 338 a 1 -acid glycoprotein (AAG), 394 Actimid, 342 Action items, 168 Active metabolites", "body": "Cyclooxygenase-1 (COX1), 21, 285 Cyclooxygenase-2 (COX2), 21, 285, 331 Cyclosporin A, 187, 194, [208] [209] 251, 341 Cystic fibrosis (CF), 86-87 Cystic fibrosis transmembrane receptor, 87 Cytochrome P450 (CYP), 90, 365-66, 448f, 1A2, 442-43, 445, 447-48 3A4, 44-5, 98, 265, 272, 376, 387-88, 415, 437, 439, 446-47 2A6, 375f 2C8, 375f 2C9, 385, 430-32, 440, 445 2C19, 92-3, 103, 430-31 2D6, 90-2, 103, 430-31, 435, 444-45 2E1, 98 Fomivirsen, 190 Food effects, 147 Forest Labs, 22, 371, 435 Formularies, tiered, 63, 103 Formulatability, 145 Formulation, 472, solution, 414 suspension, 337, 187, 376 Natural products, 235, 46 Nelfinavir, 299, 304, 404 Neutropenia, 197 Nevirapine, 300 New Chemical Entity (NCE) Notebooks, laboratory, 122, 144 Novartis, 24, 32, 97, 322, 364 Novel targets, 142, 175, [209] [210] 265 Nucleases, 190, 101, 123 Odanacatib, 327 Offshoring, see Outsourcing, global Olanzapine, 242, 379 Omeprazole, 415 Omics, 42, 184 Omnitrope, 25 Oncology, 60, 104, 135, 203 343, 347, 366, 376, 415 Peptides, 6, 13, 303, 335, 369, 372, 415 Peptidoglycan transpeptidase, bacterial, 285 Peptidomimetics, 347, 415 Performance: evaluations, 325 levels, 85, 483 metrics for researchers, 159, 482 Perkin,William, 2 Perlegen Sciences, 96 Peroxisome proliferator-activated receptor gamma (PPAR), 177, 181, 88, [102] [103] [104] 194, 209, 211 Pfizer Inc., 9, 46, Michael, 12, 26, 33, 65 Vertex Pharmaceuticals, [10] [11] 165, 199, 230, 250, 307, 490 Vertical integration, "}